Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × Radiotherapy × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 160 Urinary Bladder Neoplasms 29 Carcinoma, Renal Cell 18 Kidney Neoplasms 16 Breast Neoplasms 13 Wilms Tumor 10 Neoplasms 9 Lung Neoplasms 9 Testicular Neoplasms 8 Neoplasm Metastasis 8 Testicular Germ Cell Tumor 6 Carcinoma, Non-Small-Cell Lung 6 Melanoma 5 Lymphoma, Large B-Cell, Diffuse 5 Endometrial Neoplasms 5 Dendritic Cell Sarcoma, Interdigitating 5 Burkitt Lymphoma 5 Vaginal Neoplasms 4 Uterine Cervical Neoplasms 4 Urethral Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Seminoma 4 Sarcoma 4 Recurrence 4 Rectal Neoplasms 4 Radiation Injuries 4 Non-Muscle Invasive Bladder Neoplasms 4 Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4

Interventions

enzalutamide 7 Prednisone 7 cabazitaxel 6 Radiosurgery 6 Docetaxel 5 Androgen Antagonists 4 Abiraterone Acetate 4 XRP6258 2 talazoparib 1 sipuleucel-T 1 rucaparib 1 pembrolizumab 1 olaparib 1 gallium 68 PSMA-11 1 fludrocortisone acetate 1 darolutamide 1 apalutamide 1 Zuclomiphene 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisolone 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 LY3023414 1 Injections 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04983095 2026-02-17

METRO

Umeå University

Phase NA Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡